Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effectiveness of Ritalin, Stimedit and Practisa in primary school children with ADHD
IRCT20160530028182N10Phase 2Completed
- Sponsor
- Kurdistan University of Medical Sciences
- Start
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of methylphenidate and rivaroxaban in attention deficit hyperactivity disorder (ADHD) (3 arms), sponsored by Kurdistan University of Medical Sciences. Started Jun 2023; status: completed.
02
Drugs
methylphenidaterivaroxaban
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on IRCT20160530028182N10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20160530028182N10.